Arnuity® Ellipta® (fluticasone furoate) – Expanded indication
May 21, 2018 - GlaxoSmithKline announced the FDA approval of Arnuity Ellipta (fluticasone furoate) for the maintenance treatment of asthma as prophylactic therapy in patients aged 5 years and older.
Download PDF
